APA (7th ed.) Citation

R, S., S, N., V, P., G, V., V, P., & S, S. (2026). Ruxolitinib phosphate-laden nanoemulgel: Amelioration of ex vivo permeation and in vivo therapeutic efficacy for the effective therapeutic management of psoriasis. Inflammopharmacology, 34(7), 4831. https://doi.org/10.1007/s10787-026-02286-3

Chicago Style (17th ed.) Citation

R, Sreya, Nene S, Pathade V, Vambhurkar G, Phatale V, and Srivastava S. "Ruxolitinib Phosphate-laden Nanoemulgel: Amelioration of Ex Vivo Permeation and in Vivo Therapeutic Efficacy for the Effective Therapeutic Management of Psoriasis." Inflammopharmacology 34, no. 7 (2026): 4831. https://doi.org/10.1007/s10787-026-02286-3.

MLA (9th ed.) Citation

R, Sreya, et al. "Ruxolitinib Phosphate-laden Nanoemulgel: Amelioration of Ex Vivo Permeation and in Vivo Therapeutic Efficacy for the Effective Therapeutic Management of Psoriasis." Inflammopharmacology, vol. 34, no. 7, 2026, p. 4831, https://doi.org/10.1007/s10787-026-02286-3.